About Curium Pharma
Curium Pharma is a company based in Paris (France) founded in 2017. It operates as a Direct-to-Consumer (D2C), Professional Services, and HealthTech. Curium Pharma has completed 4 acquisitions, including Cyclopharma, Monrol and NUCLEIS. Curium Pharma offers products and services including Radiopharmaceuticals, Generators, Cold Kits, and Hot Products. Curium Pharma operates in a competitive market with competitors including ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Curium Bidco Sarl
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Cyclopharma
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curium Pharma
Curium Pharma offers a comprehensive portfolio of products and services, including Radiopharmaceuticals, Generators, Cold Kits, and Hot Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Radiopharmaceuticals are developed for diagnosis and treatment purposes.
Generators are provided for nuclear medicine diagnostic applications.
Cold kits are supplied for radiopharmaceutical preparation processes.
Hot products are offered for immediate medical use.
Unlock access to complete
Software Development Team
74 people
Leadership Team
39 people
Product Management Team
21 people
Sales and Marketing
20 people
Senior Team
15 people
Operations Team
12 people
Finance and Accounting
10 people
Human Resources and Administration
6 people
Unlock access to complete
Funding Insights of Curium Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2017 | Amount | Seed - Curium Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Curium Pharma
Curium Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CapVest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CapVest is recognized as a leading private equity investor.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Curium Pharma
Curium Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cyclopharma, Monrol and NUCLEIS. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
PET radio-pharmaceutical drugs are manufactured under contract.
|
2017 | ||||
|
Radiolabeling & radiopharmaceutical manufacturing services for nuclear medicine and molecular imaging
|
2013 | ||||
|
Radiopharmaceuticals for molecular imaging are developed and manufactured.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Curium Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Curium Pharma Comparisons
Competitors of Curium Pharma
Curium Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| domain | founded_year | HQ Location |
Disease-modifying treatments for neurodegenerative diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Curium Pharma
Frequently Asked Questions about Curium Pharma
When was Curium Pharma founded?
Curium Pharma was founded in 2017.
Where is Curium Pharma located?
Curium Pharma is headquartered in Paris, France.
Who is the current CEO of Curium Pharma?
Renaud Dehareng is the current CEO of Curium Pharma.
What does Curium Pharma do?
Curium Pharma is established as a global leader in the field of nuclear medicine, specializing in radiopharmaceuticals. The company is focused on the development and supply of innovative products used for the diagnosis and treatment of various diseases. Operations are conducted across multiple sectors within healthcare, with solutions provided to over 35,000 patients daily. A diverse portfolio including generators, cold kits, and hot products is maintained, ensuring high-quality care through a network spanning over 70 countries. Commitment to safety and reliability is emphasized in every aspect of production and delivery.
Who are the top competitors of Curium Pharma?
What products or services does Curium Pharma offer?
Curium Pharma offers Radiopharmaceuticals, Generators, Cold Kits, and Hot Products.
How many acquisitions has Curium Pharma made?
Curium Pharma has made 4 acquisitions, including Cyclopharma, Monrol, and NUCLEIS.
Who are Curium Pharma's investors?
Curium Pharma has 1 investor. Key investors include CapVest.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.